Best MRI of one area doctors in Turkey: TOP 305 doctors

Education

Istanbul University Cerrahpaşa Faculty of Medicine, 2002
Istanbul Fatih Sultan Mehmet Training and Research Hospital, Internal Medicine, 2010
Istanbul University Oncology Institute (Çapa), Medical Oncology, 2015
Medipol University Faculty of Medicine, Phytotherapy Education, 2018
University of Health Sciences, Vocational School of Health, Molecular Oncology, PhD Program, PhD, 2023

Experience

University Hospital, Newark, New Jersey, USA, Observer (2003-2004)
Siirt State Hospital, Internal Medicine (2010-2011)
Siirt State Hospital, Medical Oncology (2015)
Bakırköy Dr. Sadi Konuk Training and Research Hospital, Medical Oncology (2015-2018)
Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Medical Oncology, (Professor Doctor) (2018-Present)
Forensic Medicine 3. Specialization Board, Medical Oncology, Full Member (2019-Present)
Liv Hospital, Ulus, Park-time, Medical Oncology (2020-2022)
Şişli Kolan International Hospital, Park-time, Medical Oncology (2022-2023)

Medical Intrests

• Gastrointestinal System Tumours (Esophagus - Stomach and Large Bowel Cancer)
• Hepatobiliary System Tumours (Liver-Biliary Tract and Pancreatic Cancer)
• Breast Cancer
• Lung Cancer
• Genitourinary Cancers
• Immunotherapies and Target Therapies
• Molecular Oncology
• Immunotherapies
• Target Treatments
•  

Awards

2010-YDUS (Subspecialty Examination) 14th place in Turkey
2014- Oncology Institute Days Best Poster Award
2015- Turkish Medical Oncology Society Board Exam Qualification
2015- ESMO (European Society for Medical Oncology) Board Exam Qualification

Education

Doctor: Kilis Merkez No. 1 Health Center, 2006-2008
Assistant Doctor: Mersin University Faculty of Medicine, 2009-2013
Specialist Doctor: Bingöl Genç State Hospital, 2013-2014
Minor Assistant: Akdeniz University Faculty of Medicine, 2014-2017
Minor Specialist: Erzurum Regional Training and Research Hospital, 2017-2018
Subspecialist: Gaziosmanpaşa Training and Research Hospital, 2018-2020
Attending Specialist: Başakşehir Çam and Sakura City Hospital, 2020-2022
Associate Professor: Başakşehir Çam and Sakura City Hospital, 2023
Associate Professor: Istinye University Medicalpark Gaziosmanpaşa Hospital, 2023-2024

Scientific Memberships

Turkish Pediatric Society
Turkish Society for Pediatric Gastroenterology Hepatology and Nutrition
ESPGHAN - European Society for Pediatric Gastroenterology Hepatology and Nutrition.

Medical Intrests

• 
  -Irritable (Restless) Bowel Syndrome
• -Food allergies associated with the digestive system
• -Constipation, faecal incontinence
• -Acute and chronic diarrhoea, malabsorption
• -Chronic abdominal pain
• -Gastroesophageal reflux disease
• -Celiac disease
• -Ulcerative colitis, Crohn's disease
• -Treatment before and after liver transplantation
• -Acute and chronic pancreatitis

EDUCATION:

• Turhan and Mediha Tansel Primary School (1979–1984)
• Kültür College (1984–1988)
• Semiha Şakir High School (1988–1991)
• Marmara University Faculty of Medicine (1991–1997)
• Marmara University Faculty of Medicine, Neurosurgery Department, Specialist Training (1997–2002)
• Title of Associate Professor in Neurosurgery (May 31, 2021)

ADDITIONAL TRAINING:

• "Visiting Physician," University of Southern California, Department of Neurosurgery (1998)
• "Microsurgery Training," GATA (Gülhane Military Medical Academy), Ankara Education and Research Hospital (2003)

PROFESSIONAL EXPERIENCE:

• Gülhane Military Medical Academy Haydarpaşa Training and Research Hospital (2002–2003)
• Dr. Lütfi Kırdar Kartal Training and Research Hospital (2003–2005)
• Private Avicenna Ataşehir Hospital (2005–2012)
• Private 29 Mayıs Hospital (2012–2013)
• Maltepe State Hospital (2013–2018)
• Kartal Dr. Lütfi Kırdar City Hospital (2018–2020)
• Private Academic Hospital (2020–2022)
• Hisar Intercontinental Hospital (2022–2024)
• Private Medipol Acıbadem Regional Hospital (2024–Present)

ADMINISTRATIVE AND ACADEMIC ROLES:

• Board Member, Neurosurgical Society (2006–2009)
• Head of the Emergency Department, Maltepe State Hospital (2014–2016)
• Deputy Chief Physician, Private Academic Hospital (2020–2021)
• Advisory Board Member, Beykent University Faculty of Medicine (2018–2024)
• Faculty Member, Galata University Faculty of Health Sciences (2022–2024)
• Director, Continuous Education Center, Galata University (2022–2024)

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology

Education:

• 2004-2011: İnönü University Faculty of Medicine
• 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
• 2017-2022: Health Sciences University, Medical Oncology

Professional Experience:

• 2016-2017: Bingöl City Hospital, Internal Medicine
• 2021-2022: Health Sciences University, Medical Oncology
• 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
• 2023-2024: Ohio State University, Medical Oncology
• 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

Clinical Trials, Courses, Certifications:

Clinical Trials:

• 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
• 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

Courses:

• 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
• 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
• 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
• 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
• 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

Certifications:

• Ongoing: ECFMG Certification
• 2024: CITI Responsible Conduct of Research (The Ohio State University)
• 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
• 2024: CITI Human Subjects Protection (The Ohio State University)
• 2024: CITI Good Clinical Practice (The Ohio State University)
• 2023: Occupational English Test (OET)
• 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
• 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
• 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

Memberships:

• American Society of Clinical Oncology (ASCO) - 2022
• Turkish Society of Medical Oncology - 2020

EDUCATION:

2000 - SSK Okmeydanı Training and Research Hospital, .

1996 - Istanbul University, Istanbul Faculty of Medicine

EXPERIENCE:

2019 - Istanbul Medipol University Pendik Hospital

2017 - 2019 - Private Adatıp Kurtköy Hospital

2005 - 2017 - Private Avicenna Umut Hospital

2003 - 2005 - SSK Yalova Regional Hospital

2002 - 2003 - Kayseri Military Hospital

My 34 years of medicine – which is more than half my life… After thousands of surgeries, the excitement and sense of responsibility of the first day still outweigh it. My father was a doctor, a neurologist too. I would always give the same response to those asking what I would be in elementary and secondary school: Neurosurgeon. When I started my neurosurgery residency at Haydarpaşa Numune Hospital in 1992, my childhood goal was fulfilled. Two points have always stood out from the others throughout my medical career: 1. Don’t harm anyone. 2. The most important relationship between the doctor and patient is the relationship of trust. In line with the principle of “first do no harm” in Turkish with “primum non nocere” in Latin, I have always preferred to perform secured surgeries under the microscope from smaller incisions. I didn’t perform any surgery that I wasn’t sure the patient would benefit from. So I’ve always been in a position to convince myself first of the need for surgery. Then I convince my patient. I kept in mind that the most important relationship between surgeon and patient is the relationship of trust. How can a person entrust his life to someone he saw 15 minutes ago without a relationship of trust? I cared about this relationship lasting post-surgery and even for life. I’ve had the first walks of my patients that I’ve operated in 28 years. Sometimes even after midnight many times… I’ve always cared about some patients’ feeling of their need to see their physician even at 03.00 o’clock midnight. I don’t mind giving all my patients my cell phone number. I would want my physician to be available at any time as needed. That’s what I do for my patients. In these lines, I felt the need to describe my view of medicine. Anyone who wonders anyway can reach my resume and my publications.

Prof. Dr. Halil Ibrahim Bekler was born in Istanbul in 1960. He completed his primary school education in Istanbul. He finished High School in Saint-Joseph in 1979. In 1985 he graduated from the Istanbul Faculty of Medicine. In the same year, he started to work as a resident doctor at Tokat Akbelen Health Center. Between 1987 and 1991, he specialized in Orthopedics and Traumatology at SiSli Etfal Hospital. Between 1993 and 1994, he worked as an assistant professor at Dicle University Faculty of Medicine in Diyarbakır, Turkey. Later, he worked as the Head of the Orthopedic and Traumatology Surgery Department at American Hospital. In 1999, he studied microsurgery at Cleveland Medical Center.
He worked as a specialist in Orthopedics and Traumatology Microsurgery in many private hospitals in Istanbul. Between 2006-2007, he worked as a Hand and Microsurgery Specialist at Columbia University School of Medicine. In 2008, he became an associate professor of orthopedics at Yeditepe University Faculty of Medicine. Between 2009 and 2015, he worked as Chief of Orthopedics at Lütfi Kırdar Kartal Hospital and he trained many Assistant Specialists. He became Professor in 2016.

He performs orthopedic microsurgery procedures at Avicenna Atasehir Hospital and offers effective treatments for knee and hip prostheses in the field of Orthopedics and Traumatology.

Prof. Dr. Ceyhun Bozkurt is a respected Pediatric Hematologist-Oncologist. He is known for his work in childhood blood disorders and cancers. He graduated from Cerrahpaşa Faculty of Medicine. He holds specializations in both Pediatrics and Pediatric Oncology. Since 2019, he has been Professor and Clinical Director at Bahçelievler Medical Park Hospital. He also serves as Vice Director of the Stem Cell Transplant Unit.

Dr. Bozkurt has published over 40 peer-reviewed articles. He is recognized for his work in leukemia, bone marrow transplantation, and stem cell therapy. He is a member of organizations such as SIOP and EBMT. His memberships show his dedication to high standards in clinical care and research.

Education and Specialization

• Bachelor’s Degree: Çukurova University Faculty of Medicine (1987/1993)
• Medical Specialization: Department of Pediatrics, Fırat University (1993/2001)
• Subspecialty: Pediatric Neurology Unit, Hacettepe University (2002/2004)

Professional Experience

• General Practitioner: Mardin State Hospital, Emergency Department (1993/1996)
• Research Assistant: Faculty of Medicine, Fırat University (1996/2001)
• Lecturer: Faculty of Medicine, İnönü University (2001/2002)
• Subspecialty Research Assistant: Faculty of Medicine, Hacettepe University (2002/2004)
• Assistant Professor: Faculty of Medicine, İnönü University (2004/2008)
• Associate Professor: Faculty of Medicine, İnönü University (2008/2014)
• Professor: Faculty of Medicine, İnönü University (2014/2023)

Education and Specialization

• Bachelor’s Degree in Medicine (English) – Hacettepe University, 1997
• Master’s Degree – Department of Internal Medicine, Akdeniz University, 2004
• Ph.D. / Proficiency / Medical Specialization – Division of Gastroenterology, Akdeniz University, 2007

Experience

• Akdeniz University Faculty of Medicine 1998/2004
• Akdeniz University Faculty of Medicine  2004/2007
• Urfa Training and Research Hospital 2008/2009
• Akdeniz University Faculty of Medicine, Department of Internal Medicine, Division of Gastroenterology  2010/2011
• Akdeniz University Faculty of Medicine, Department of Internal Medicine, Division of Gastroenterology 2011/2013
• Akdeniz University Faculty of Medicine, Department of Internal Medicine, Division of Gastroenterology 2013/2017
• Medical Park Antalya Hospital, Gastroenterology Department and Organ Transplant Center

Pediatric Cardiology

Pendik Medipol University Hospital

Experience

2021 Private Nisa Hospital

2020 – 2021 Bezmialem Foundation University Faculty of Medicine

2015 – 2021 Bezmialem Foundation University Faculty of Medicine

2010- 2015 Izmir Dr. Behçet Uz Pediatric Training and Research Hospital

2008 – 2009 Gata Pediatric Cardiology 

1999 – 2003 Merzifon Aviation Medicine Center

Education

2006 Gülhane Military Medical Academy, Pediatric Cardiology

1998 Gülhane Military Medical Academy, Child Health and Diseases

1991 Gülhane Military Medical Academy, Faculty of Medicine

Gastroenterology

Pendik Medipol University Hospital

Education

1999 Karadeniz Technical University, Gastroenterology

1997 Atatürk University, Internal Diseases Professorship

1992 Atatürk University, Internal Diseases Associated Professorship

1985 Atatürk University, Internal Diseases Specialist

1981 Atatürk University Faculty of Medicine

Publications

1- Nihat Okçu Gülçin Polat, Arif Yılmaz, Mehmet Koruk, The demographic features of gastric cancers in Erzurum(Eurasian J Med 2000; 32: 63-65)

2- An Evaluation of Upper Gastrointestinal Bleeding Cases. Clinical Sciences-Doctor.2000, - E.akarsu,N.Okçu,et Ark.Northeast Anatolia 6:4:435-438

3-N.Okçu, A.yılmaz. İ.kiki,MDonuk, C.gündoğdu, H.uzunismail. Our Diagnostic Upper Gastrointestinal Endoscopy Results. Atatürk University Medical Journal 1997,29 (2):486

4-N. Okçu, M.gündoğdu, MD onuk, İ.kiki, l.cerrahoğlu, k.yılmaz, I. çapoğlu. The Role of Misoprostol in Preventing Gastroduodenal Lesions in Patients Using Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). Atatürk University Medical Journal 1997,29 (2):453-455.

5-N.Okçu, A. Öz, MD Onuk, E.Akarsu, B. Tekin, Hz Tonbul, H.Kaya. Plasma Fibronectin Levels in Chronic Active Hepatitis and Decoction of Liver Parenchymal Insufficiency and Their Relationship with Liver Functional Status. Turkish J. Gastroenterol 1995;27(4): 422-426.

6-N.Okçu, Tahir Buran, MD Onuk, A. Yılmaz, E.Akarsu, G. Akçay. Prevalence of Helicobacter Pylori in Patients with Duodenal Ulcer in Erzurum and Surrounding Area. Turkish J. Gastroenterol 1995;27(4): 447-450.

7-N.Okçu, bs awake, e. akarsu, e. bakan, z. tonbul. Importance of Carbohydrate Antigens (CA-19-9, CA-125), Carcinoembryonic Antigen (CEA) and Alkaline Phosphatase in Gastric and Colorectal Cancers. Turkish J. Gastroenterol 1995;6:467-471.

8-N. Okçu, MD Onuk, E. Akarsu, H. Doğan, C. Gündoğdu. Major Risk Factors in Patients with Hepatocellular Carcinoma in Our Region. Gastroenterology 1994;5(2):154-157

9-N.Okçu, md. Onuk, e. akarsu, h. doğan, c.gündoğdu, tahir buran. Frequency of gastric carcinoma in Erzurum region, endoscopic and histological features. Gastroenterology 1994;5(2):263-267.

10-N. Okçu, MD Onuk, Tahir Buran, E. Akarsu, MA Çiftçioğlu. Frequency of Helicobacter Pylori in Nonspecific Gastritis Cases in Erzurum Province. Gastroenterology 1994;5(2):211-213.

11-N.Okçu, MD Onuk, Ö. Ünal, E. Akarsu, L. İncesu, K. Akgöz. Diagnostic Value of Ultrasound-Guided Fine Needle Aspiration Biopsy in Intra-Abdominal Mass Lesions. Gastroenterology 1993;4(1):166-68.

12-NOkçu, md. onuk, m. polat, a. yılmaz, m. gündoğdu, m. paç. Budd-Chiari Syndrome (2 Cases). Turkish J Gastroenterhepatol 1993; 4(1):77-80.

13-N.Okçu, H. Koçak, MD Onuk, M. Gündoğdu, E. Bakan, A. Yılmaz, A. Başoğlu, A. Ateş, F.A. Paç. The Effect of Atrial Pressure Changes and Cardiac Nerves on Plasma Atrial Natriuretic Peptide (ANP) Levels. Vascular Surgery 1993; 27(2): 128-132

15-N.Okçu, MD Onuk, A.Yılmaz, M. Gündoğdu, T. Buran. Effects of Omeprozole and Ranitidine on Peptic Ulcer Healing. Doğa-Tr.J. of Medical Sciences 1992;16:657-658.

16-N. Okçu, Mr. Yiğitoğlu, B. Adam, E. Bakan. The Effect of Digixin on Plasma Atrial Natriuretic Peptic Level in Patients with Congestive Heart Failure. S.Ü. Medical Faculty Journal 1991;7(2):243-247..

17-N.Okçu, A. Yılmaz. The Effect of Histamine H2 -Receptor Antagonists in Upper Gastrointestinal System Bleeding. Endoscopy Journal 1991;2(4):17-23.

18-N.Okçu, E. Bakan, B. Adam, A. Yılmaz, Mr. Yiğitoğlu. Sex Hormones and Sex Hormone Binding Globulin Levels in Patients with Chronic Hepatitis and Liver Cirrhosis (Letter to the Editor). Nature-Tr. J. Of Medical Sciences 1991;15:1-2.

19-N.Okcu Ömer Yılmaz.Helıcobacter pylori and related gastrointestinal system diseases. Turkish Clinics JMed Sci. 2013;33(3):806-13

20-Nihat Okçu, Ömer Yılmaz, Hakan Dursun, Gülçin Polat. The relationship between dyspeptic symptoms, nutritional habits, endoscopic and histological findings (Eurasian J Med 2006; 38: 13-17)

21-Mehmet Bilici,1Nihat Okcu,1Kerim Cayir,1Ibrahim Pirim,2Salim B. Tekin,1andCemal Gundogdu3 - Distribution of HLA Tissue Groups in Patients with Gastric Cancer Eurasian J Med. 2010 Apr; 42(1): 9.11.

22-Nihat Okcu,Abdulhalim Bak,Mehmet Sari,Mehmet Arslan,Sait Kapicioglu:The fibroblast proliferation, relationship of hepatocyte growth factor (HGF) and interferon-A2A Gastroenterology April 2000Volume 118,Issue 4, Part 2, PageA1404

23-Kubra Kaynar,Sait Kapicioglu,Mehmet Sari,Nihat Okcu,Abdulhalim Baki. The effect of fish oil on stress ulcer prophylaxis GastroenterologyVolume 118, Issue 4, Part 2, PageA1255

Experience

2018

Private Istanbul Medipol Hospital

2018

Medipol University Camlica Hospital

2018

Medipol Camlica Hospital

2013 - 2018

Medipol Mega University Hospital

2011 - 2013

Yuzuncu Yil University Hospital

2010 - 2011

Gulhane Military Medical Academy

2010 - 2013

Yuzuncu Yil University Hospital

2010 - 2011

Gulhane Military Medical Academy

2010 - 2011

Gulhane Military Medical Academy

2010 - 2013

Yuzuncu Yil University Faculty of Medicine

2009

University of Toronto SickKids Hospital

2004 - 2008

Private Van-Etfal Pediatric Diseases

1999 - 2004

Yuzuncu Yil University Hospital

Education

2010

Yuzuncu Yil University, Pediatric Nephrology

2004

Yuzuncu Yil University, Pediatrics

1998

Ege University, Faculty of Medicine

Experience

2017 - 2020 Acıpayam State Hospital

2016 - 2017 Izmir Public Health Laboratory

2013 - 2016 Bozyaka Training and Research Hospital

2011 - 2013 Pendik State Hospital

2011 - 2011 Midyat State Hospital

2004 - 2010 Dokuz Eylul University Faculty of Medicine

Acipayam State Hospital

Izmir Public Health Laboratory

Bozyaka Training and Research Hospital

Pendik State Hospital

Midyat State Hospital

Dokuz Eylul University Faculty of Medicine

Education

2010 Dokuz Eylul University Faculty of Medicine, Infectious Diseases and Clinical Microbiology

2010 Dokuz Eylul University Faculty of Medicine, Infectious Diseases and Clinical Microbiology

2004 Ege University, Faculty of Medicine

2004 Ege University, Faculty of Medicine

Publications

ARTICLES PUBLISHED IN INTERNATIONAL REFEREED JOURNALS

Bulent Ertugrul, Çağrı Buke, Özlem Saylak Ersoy, Bengisu Ay, Dilek Senen Demirez, Öner Savk. Intralesional epidermal growth factor for diabetic foot wounds: the first cases in Turkey. Diabetic foot and ankle.6: August 2015

Vedat Turhan, Günalp Uzun, Mustafa Hatipoglu, Mesut Mutluoglu, Erol Sevim, Hayati Demiraslan, Esma Eryılmaz, Cem Ozuguz, Ali Memis, Turk-Day Working Group (Hakan Ay, Bilgin Arda, Serhat Uysal, Vicdan Koksaldi Motor, Cigdem Kader, Ayse Erturk, Omer Coskun, Fazilet Duygu, Selma Guler F. Aybala Altay, Aziz Ogutlu, Sibel Bolukcu, Ozlem Kandemir, Halide Aslaner, Arife Polat, Mustafa Karahocagil, Kadriye Kart Yasar, Emine Sehmen, Sirri Kilic, Mustafa Sunbul, Serap Gencer, Fatma Bozkurt, Tugba Yanik, Nefise Oztoprak Cuvalci, Ayse Batirel, Hamdi Sozen, Inci Kilic, Ilhami Celik, Bengisu Ay, Selma Tosun, Ayten Kadanali, Senol Comoglu, Affan Denk, Salih Hoşoğlu, Özlem Aydın, Nazif Elaldı, Şerife Akalın, Bahar Kandemir, Ayhan Akbulut, Tuna Demirdal, Recep Balık, Emel Azak, Gönül Şengöz); Causative pathogens and antibiotic resistance in diabetic foot infections: A prospective multi-center study. Journal of Diabetes and its Complications, Volume 30, Issue 5, July 2016,910-916

Alpay Arı, Ali Ilgın Olut, Bengisu Ay, Selma Tosun, Meltem Zencir, Mehmet Umut Çayıröz. A small outbreak of Serratia liquefaciens bacteremia due to use of contaminated saline infusion solution for myocardial perfusion scintigraphy. Journal of Infectious Diseases, Volume 49, 2017, 639-40

B- PAPERS PRESENTED IN INTERNATIONAL SCIENTIFIC CONFERENCES AND PUBLISHED IN PROCEEDINGS

Vedat Turhan, Günalp Uzun, Mustafa Hatipoglu, Mesut Mutluoglu, Erol Sevim, Hayati Demiraslan, Esma Eryılmaz, Cem Ozuguz, Ali Memis, Turk-Day Working Group (Hakan Ay, Bilgin Arda, Serhat Uysal, Vicdan Koksaldi Motor, Cigdem Kader, Ayse Erturk, Omer Coskun, Fazilet Duygu, Selma Guler F. Aybala Altay, Aziz Ogutlu, Sibel Bolukcu, Ozlem Kandemir, Halide Aslaner, Arife Polat, Mustafa Karahocagil, Kadriye Kart Yasar, Emine Sehmen, Sirri Kilic, Mustafa Sunbul, Serap Gencer, Fatma Bozkurt, Tugba Yanik, Nefise Oztoprak Cuvalci, Ayse Batirel, Hamdi Sozen, Inci Kilic, Ilhami Celik, Bengisu Ay, Selma Tosun, Ayten Kadanali, Senol Comoglu, Affan Denk, Salih Hoşoğlu, Özlem Aydın, Nazif Elaldı, Şerife Akalın, Bahar Kandemir, Ayhan Akbulut, Tuna Demirdal, Recep Balık, Emel Azak, Gönül Şengöz); Current Bacterial Etiology And Antimicrobial Resistance In Dfıs; A Multicenter Prospective Trial Of “Turk-Day”. Congress of Balkan Millitary Medical Committee, 8-11 June 2015, Greece

C- ARTICLES PUBLISHED IN NATIONAL REFEREED JOURNALS

VildanAvkan Oğuz, Bengisu Ay, Vasfi Karatosun, Zeynep Gülay; A Case of Total Knee Arthroplasty in which Aeromonas Hydrophila Was Isolated in Perioperative Culture: Trakya Univ Medical Faculty Journal, 2009

Şebnem Çalık, Bengisu Kara Ay, Arif Yüksel, Kamuran Çapcıoğlu, Meltem Zencir, Ümran Bingöl, Neslihan Genç, Meltem Avcı, Selma Tosun. Evaluation of the knowledge level and vaccination status of individuals in the risk group recommended for influenza vaccination. Medical Journal of İzmir Hospital 2013; 17 (4): 241-245

B Ay, S Calik, B Karaca, S Tosun. Atypical Mediterranean spotted fever: First case from Aegean Region. Izmir Tepecik Education and Research Hospital Journal. 2016; 26(2):175-177

B Ay, E Ozdemir, N Unel, S Calik, B Karaca. Telbivudine-Related Myopathy: A Case Report. Viral Hepat J 2016; 22: 37-38

D- PAPERS PRESENTED IN NATIONAL SCIENTIFIC MEETINGS AND PUBLISHED IN PROCEEDINGS

Şebnem Çalık, Bengisu Kara Ay, Arif Yüksel, Kamuran Çapcıoğlu, Meltem Zencir, Ümran Bingöl, Neslihan Genç, Meltem Avcı, Selma Tosun. Evaluation of the knowledge level and vaccination status of individuals in the risk group who are recommended to receive influenza vaccination. 5th National Vaccine Symposium, 25-29 September 2013, Ankara

''Evaluation of 4 Patients Receiving Telaprevir for Chronic Hepatitis C'' “Speech 7" Istanbul – Marriott Asia Hotel; 'Our Turkey Teleprevir Experience Symposium, 21 September 2013'

Bengisu Ay, Alpay Arı, Nalan Ünel, Erman Özdemir, Selma Tosun; Our experience with telaprevir in two centers: 12th National Viral Hepatitis Congress, 26-29 March 2014, Belek/Antalya

Bengisu Ay, Erman Özdemir, Nalan Ünel; Myopathy side effect of telbivudine treatment due to a case: 12th National Viral Hepatitis Congress, 26-29 March 2014, Belek/Antalya

Gülsüm Altın, Aslı Keleş, Bengisu Ay, Ebru Dik, Meltem Zencir, Halil Erkan, Selma Tosun. Evaluation of the differences and knowledge levels of individuals in the society about the transmission routes of Hepatitis B virus. BUHASDER 6. Tepecik Infection Days Symposium. 04-08 November 2015 Muğla.

Vedat Turhan, Günalp Uzun, Mustafa Hatipoglu, Mesut Mutluoglu, Erol Sevim, Hayati Demiraslan, Esma Eryılmaz, Cem Ozuguz, Ali Memis, Turk-Day Working Group (Hakan Ay, Bilgin Arda, Serhat Uysal, Vicdan Koksaldi Motor, Cigdem Kader, Ayse Erturk, Omer Coskun, Fazilet Duygu, Selma Guler F. Aybala Altay, Aziz Ogutlu, Sibel Bolukcu, Ozlem Kandemir, Halide Aslaner, Arife Polat, Mustafa Karahocagil, Kadriye Kart Yasar, Emine Sehmen, Sirri Kilic, Mustafa Sunbul, Serap Gencer, Fatma Bozkurt, Tugba Yanik, Nefise Oztoprak Cuvalci, Ayse Batirel, Hamdi Sozen, Inci Kilic, Ilhami Celik, Bengisu Ay, Selma Tosun, Ayten Kadanali, Senol Comoglu, Affan Denk, Salih Hoşoğlu, Özlem Aydın, Nazif Elaldı, Şerife Akalın, Bahar Kandemir, Ayhan Akbulut, Tuna Demirdal, Recep Balık, Emel Azak, Gönül Şengöz); Current Causative Microorganisms and Antimicrobial Susceptibilities in Diabetic Foot Infection; A Multicenter Study “TURK-DAY”. 5th EKMUD Scientific Platform, 01-04 April 2015, İzmir.

Education

2019

Istanbul Faculty of Medicine, Electroneurophysiology

2005

Istanbul University Cerrahpasa Faculty of Medicine, Neurology

1998

Istanbul University Cerrahpasa, Faculty of Medicine

Experience

2017 - 2019

Private Adatip Kurtkoy Hospital

2016

TND – Schering-Plough Proceedings of the Year Awards

2015 - 2017

Istanbul Yeni Yüzyıl University Private Gaziosmanpaşa Hospital

2015 - 2015

Şişli Hamidiye Etfal Training and Research Hospital

2005 - 2014

Private Avicenna Hope Hospital

2015 – 2019 Istanbul University Cerrahpasa Faculty of Medicine

2019 – Medipol University Pendik Hospital

Publications

1- Yüz Ağrılarında Trigeminal SEP Uygulaması ; Yüksek Lisans Tezi

2- Glial Tümörlerde P53 , PTEN ve EGRF Pozitifliğinin İmmunohistokimyasal ; Uzmanlık Tezi

3- Two siblings with homocystinuria presenting with dystonia and parkinsonism

4- Lack of association between IL-1ß/? gene polymorphisms and temporal lobe epilepsy with hippocampal sclerosis

5- Psychogenic movement disorders in two children

6- Temporal Lob Epilepsi ve Hippokampal Sklerozlu Hastalarda İnterlökin 1-ß ve İnterlökin 1-? Gen Polimorfizminin Analizi

7- Hippokampal Skleroza Bağlı Mesial Temporal Lob Epilepsisi İle İnterlökin 1-ß ve İnterlökin 1-? Gen Polimorfizmi İlişkisinin Araştırılması

Experience

2016 - 2019 Private Gebze Konak Hospital

2014 - 2015 Private Medicana Camlica Hospital

2013 - 2014 Private Batman Hospital

2011 - 2013 Batman Regional State Hospital

Uskudar University

Gazi University Faculty of Medicine

Education

2011 Bezmialem Vakıf University Faculty of Medicine, Physical Medicine and Rehabilitation

2005 Marmara University, Faculty of Medicine in English

Experience

2017 - 2019 Okan University Hospital

2019 - Medipol University Pendik Hospital

Education

2016 Marmara University Faculty of Medicine, Chest Diseases

2007 St. Cyril and Methodius University, Faculty of Medicine

Publications

1- Frequency of Immunodeficiency in Adult Non-Cystic Fibrosis Bronchiectasis Patients; Specialization Thesis

2- Canan Cimşit, Melahat Bekir, Sait Karakurt, Emel Eryüksel, Ultrasonographic evaluation of diaphragm thickness in COPD – Marmara Medical Journal 2016; 29:8-13

3- Emel Eryuksel, Canan Cimsit, Melahat Bekir, Çagatay Cimsit, Sait Karakurt, Diaphragmatic Thickness Fraction in Subjects at High Risk for COPD Exacerbations Respiratory Care December 2017

4- Melahat Bekir, T. Bahadır Üskül, Pulmonary Functions in Patients With Idiopathic Scoliosis The Journal of Turkish Spinal Surgery ; April 2017

5- Emel Eryuksel, Canan Cimsit, Melahat Bekir, Cagatay Cimşit, Sait Karakurt, Is Diaphragmatic Thickness fraction valuable in Identifying High-Risk Chronic Obstructive Pulmonary Disease Patients, European Respiratory Journal Sep 2017

6- Melahat Bekir Külah, Şehnaz Olgun Yıldızeli, Derya Kocakaya, Berrin Ceyhan, The Effect of Clinical Findings on One-Year Disease Course in Adult Bronchiectasis Patients Other Than Cystic Fibrosis, 21st Annual Congress of the Turkish Thoracic Society _ Belek, Turkey 2018

7- Melahat Bekir Külah, Şehnaz Olgun Yıldızeli Derya Kocakaya, Emel Eryüksel, Elif Karakoç Aydıner, İsmail Öğülür, Berrin Bağcı Ceyhan, Quality of Life in Adult Bronchiectasis Patients Other Than Cystic Fibrosis: The Role of Psychological Status and Disease Severity 20th Annual Congress of the Turkish Thoracic Society – Belek Türkiye 2017

8- Berrin Ceyhan, Melahat Bekir, Şehnaz olgun Yıldızeli, Derya Kocakaya , Emel Eryüksel, Validity and reliability of the Turkish version of the EMBARC (European Bronchiectasis Audit and Research Collaboration) quality of life scale in patients with non-cystic fibrosis bronchiectasis. Turkish Thoracic Society 20th Annual Congress – Belek, Turkey 2017 (POSTER AWARD WINNER)

9- Melahat Bekir, Şehnaz Olgun Yıldizeli, Derya Kocakaya, Hüseyin Arıkan, Emel Eryüksel, Berrin Bağcı Beyhan, Relationship Between Vitamin D Levels and Lung Functions, Clinical Indexes, Anxiety-Depression Symptoms in Adult Non-Cystic Fibrosis Bronchiectasis Patients – 19th Annual Congress of the Turkish Thoracic Society - Belek, Turkey 2016

10- Melahat Bekir, Derya Kocakaya, Şehnaz Olgun, Berrin Bağcı Ceyhan, Anticoagulant Treatment Approach in a Case of Venous Thrombosis Causing Superior Vena Cava Syndrome with Active Bleeding – 18th Annual Congress of the Turkish Thoracic Society – Belek, Turkey 2015

11- Melahat Bekir, Berrin Bağcı Ceyhan, Life-Threatening Bleeding After Anticoagulation with Rivaroxaban: Two Case Reports, 18th Annual Congress of the Turkish Thoracic Society – Belek, Turkey 2015

12- Şehnaz Olgun Yıldızeli, Çagatay Nuri Cimşit, Semiha Emel Eryüksel, Canan Cimşit, Melahat Bekir, Tuğçe Yakut, The Relationship of Pulmonary CT Angiography with Clinical Scores in Pulmonary Embolism – Turkish Thoracic Society 18th Annual Congress – Belek Turkey 2015

13- Melahat Bekir, Canan Cimşit, Hüseyin Arıkan, Derya Kocakaya, Şehnaz,Olgun, Semiha Emel Eryüksel, Sait Karakurt, Diaphragm Thickness in COPD Patients and Its Relationship with Symptoms, Turkish Thoracic Society 17th Annual Congress – Belek, Turkey 2014

14- Melahat Bekir Külah, Frequency of Immunodeficiency in Patients with Non-Cystic Fibrosis Bronchiectasis and its Relationship with Clinical Parameters, 20th Annual Congress of the Turkish Thoracic Society – Belek Türkiye 2017

15- Berrin Ceyhan, Melahat Bekir Külah, Şehnaz Olgun Yıldızeli, Derya Kocakaya, One Year Follow-Up of Respiratory Health Outcomes in Adult Patients with Non-Cystic Fibrosis Bronchiectasis ERS 2018

16- Melahat Bekir, Şehnaz Olgun Yıldızeli, Derya Kocakaya, Emel Eryüksel, Elif Karakoç, İsmail Öğülür Berrin Bağcı Ceyhan Immun Deficiency in Patients with Non Cystic Fibrosis Bronchiectasis and Relationship with Clinical Parameters ATS Conference 2017- Washington, DC 2017

17- Melahat Bekir Külah, Sehnaz Olgun Yildizeli, Derya Kocakaya, Emel Eryuksel, Berrin Bagci Ceyhan Health Related Quality of Life Among Adult Patients With non Cf Bronchiectasis: The Role of Psychological status and disease severity ERS International Congress 2017, Milan Italy 2017

18- Melahat Bekir, Şehnaz Olgun Yıldızeli, Derya Kocakaya, Hüseyin Arıkan, Emel Eryüksel, Berrin Bağcı Ceyhan The Relationship Between Vitamin D Level and Lung Function, Severity and Clinical Indices, Depression and Anxiety Symptoms in Adult Patients With Non-Cystic Fibrosis Bronchiectasis ATS Conference 2016 - San Francisco , California 2016

Experience

2019 – 2019

• University of Insubria, Varese, Italy, 

Insubria University Faculty of Medicine

2015

• MERSİN UNIVERSITY/FACULTY OF MEDICINE, DOCTOR, LECTURER

2013 – 2015

• ANKARA PRIVATE ACIBADEM HOSPITAL

2010 – 2012

• DIYARBAKIR TRAINING AND RESEARCH HOSPITAL,

2002 – 2003

• AYDIN 1ST PRIVATE TRAINING BATTALION
•  

Education

2010

• ANKARA UNIVERSITY FACULTY OF MEDICINE, BRAIN AND SURGERY SPECIALIST

1992

• GAZI UNIVERSITY, FACULTY OF MEDICINE